|Videos|January 21, 2021

Examining the ear exam

Andrew J. Schuman, MD, FAAP, discusses the ear exam and the importance of looking for hearing loss.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

4 Experts are featured in this series

RSV Prevention: Final Reflections and a Vision for the Future

ByFlor M. Munoz, MD, MSc,C. Buddy Creech, MD, MPH,Eric Simões, MD,Tina Q. Tan, MD, FAAP, FIDSA, FPIDS

July 20th 2026

4 Experts are featured in this series

RSV Prevention and Vaccine Hesitancy: Building Long-Term Communication

ByFlor M. Munoz, MD, MSc,C. Buddy Creech, MD, MPH,Eric Simões, MD,Tina Q. Tan, MD, FAAP, FIDSA, FPIDS

July 20th 2026

4 Experts are featured in this series

RSV Immunization Rates and Vaccine Hesitancy: Practical Strategies for Clinicians

ByFlor M. Munoz, MD, MSc,C. Buddy Creech, MD, MPH,Eric Simões, MD,Tina Q. Tan, MD, FAAP, FIDSA, FPIDS

July 13th 2026

4 Experts are featured in this series

RSV and the Challenge of Reinfection: Long-Term Prevention Perspectives

ByFlor M. Munoz, MD, MSc,C. Buddy Creech, MD, MPH,Eric Simões, MD,Tina Q. Tan, MD, FAAP, FIDSA, FPIDS

July 13th 2026

Shared Decision-Making, Adherence, and Future Directions in Pediatric IBS-C and Functional Constipation

ByJulie Khlevner, MD, AGAF

July 8th 2026

Latest CME

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

Trending on Contemporary Pediatrics

New multisociety position paper details hospital strategies to close gaps in sepsis care

CDC declares Nara Organics infant botulism outbreak over as genetic testing links it to 2025 ByHeart outbreak

Contemporary Pediatrics week in review: August 24-28, 2026

Longer treatment may yield continued improvement in pediatric anxiety

Lebrikizumab phase 3 data show improvements in atopic dermatitis symptoms, itch in children